Health ❯ Healthcare

Medical Devices

Wearable Technology Diagnostic Tools Diabetes Management Cardiology Glucose Monitoring Continuous Glucose Monitoring Artificial Intelligence Implants Regulatory Compliance Ophthalmology Regulations Patient Safety Artificial Hearts Diagnostic Tests Neurology Blood Pressure Monitors Diabetes Care Continuous Glucose Monitors Manufacturing Regulatory Approval Pacemakers Hemostatic Agents Product Safety Regulatory Affairs Artificial Organs Cancer Screening Insulin Pumps Opioid Overdose Glucose Monitors Product Recalls Infection Control Industry Support Regulatory Issues Air Purifiers AI in Healthcare Sleep Apnea Regulatory Approvals Pulse Oximeters Cochlear Implants Insulin Delivery Systems Surgical Robots Inhalers Drug Delivery Surgical Instruments Diabetes Technology Prosthetics Neurostimulation Regulation Blood Tests Drug Delivery Systems Surgical Procedures Clinical Trials Weight Loss Spinal Cord Stimulators Adrenaline Autoinjectors Therapeutic Innovations Unauthorized Devices Obesity Treatments Plastic Materials Importation Hospital Equipment Biomimetic Technology Robotic Surgery Regulatory Frameworks Rehabilitation Equipment Transvenous Phrenic Nerve Stimulation Microcatheters Cancer Detection Left Ventricular Assist Devices Consumer Health Products Regulatory Process Device Safety MedSurg Division Gastroesophageal Reflux Disease MRI Technology Transvaginal Mesh Needle-Free Technology Dexcom Hearing Aids Injectors Breast Cancer Supply Chain Cardiac Devices Abbott Laboratories Drug-Eluting Stents Vaginal Mesh Implants Safety Remote Monitoring Diabetes Treatment Heart Monitors Heart Monitoring Ultrasound Technology Wound Healing Prescription Management Home Sleep Testing Pharmaceuticals Catalytic Technology Device Recalls Infection Prevention Interventional Cardiology

Australia Clears Apple Watch Hypertension Alerts as Medical Device

The regulatory listing covers a pattern‑detection feature that flags possible high blood pressure from month‑long optical heart‑sensor trends.

FDA-Approved AI Tool Shows Promise for Faster Autism Diagnosis in Rural Primary Care

FDA Approves Rybrevant Faspro, a 5‑Minute Subcutaneous Amivantamab for EGFR‑Mutated Lung Cancer

DexCom Securities Suits Intensify as Firms Seek Lead Plaintiffs

DexCom Investor Suits Intensify as Firms Set Competing Lead-Plaintiff Deadlines

Cooper Investors Posts Flat Q3, Highlights TKO and CME, Details GE HealthCare Exit

Baxter Investors Face Dec. 15 Lead-Plaintiff Deadline in Novum Pump Securities Suit

FDA Issues Early Alert on Certain FreeStyle Libre 3 Sensors After False Low Readings Linked to Harm

FDA Names Tracy Beth Høeg Acting CDER Director as OTC Drugs Chief Is Reassigned

Carillon Q3 Mid-Cap Growth Letter Highlights AI-Fueled Rally, Value’s Edge, and Three Pivotal Stock Updates

Baxter Investors Face Dec. 15 Deadline To Seek Lead Role In Securities Suit Over Novum IQ Pump

DexCom Investors Face Late-December Deadlines in Suits Over FDA-Flagged CGM Changes

Inspire Medical Investors Press Class Action Over Inspire V Rollout With Lead-Plaintiff Deadline Jan. 5

DexCom Faces Wave of Securities Class Actions Over FDA-Faulted CGM Changes

Baxter Investors Urged to Seek Lead Role in Novum Pump Securities Cases Before Dec. 15 Deadline

Inspire Medical Faces Investor Class Actions Over Inspire V Rollout

Baron Health Care Fund Details Q3 Letter: Adds AbbVie, Rebuys UnitedHealth as Stock Picking Edges Benchmark

FDA Issues Safety Alert on RF Microneedling Injuries

Alger Weatherbie Trails Benchmark in Q3 as Vertex Cuts Outlook and Artivion Raises Guidance

Orchestra BioMed Starts U.S. Virtue Coronary Balloon Trial as Terumo Reworks Deal With $30M Support